Literature DB >> 1299387

Spectrophotometric absorbance of follicular fluid: a selection criterion.

C Huyser1, F L Fourie, L Wolmarans.   

Abstract

PURPOSE: The aim of this study was to ascertain the absorbance profiles of uncontaminated follicular fluids (FF) vs blood and medium contaminated FF, and to test the hypothesis that blood contamination alters the biochemical status of FF.
METHODS: FF (n = 655) from 230 patients were scanned spectrophotometrically during an ongoing in vitro fertilization (IVF) program. Based on spectrophotometric evaluation, blood contaminated and uncontaminated FF (n = 39 patients/FF) were analyzed for electrolyte content, inorganic phosphate, glucose, creatine, urate, total protein, albumin, bilirubin, cholesterol, alkaline phosphatase, gamma-glutamyltransferase, alanine aminotransferase, aspartate transaminase, and lactate dehydrogenase by means of a SMAC analyzer.
RESULTS: Laparoscopic aspiration resulted in the collection of significantly more clear FF compared to the transvaginal procedure (P = 0.001). Uncontaminated fluid depicted a single mean absorbance at 458.0 nm. Blood contaminated FF could be identified by spectrophotometry and revealed three peaks at 418.12, 540.13, and 575.32 nm, respectively, according to the degree of blood contamination. Follicular fluid diluted with Earles Balanced Salt Solution (EBSS) displayed an additional mean peak at 561.4 nm. Potassium, glucose, and all of the above mentioned enzymes revealed significantly higher levels in blood contaminated FF (P < 0.05).
CONCLUSIONS: From this study, it is concluded that blood contamination and dilution with culture medium influence the biochemical composition as well as the absorbance spectrum of follicular fluids. This procedure is advocated as a prerequisite before quantifying FF content.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1299387     DOI: 10.1007/bf01204251

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  23 in total

1.  Influence of light on the hyperbilirubinaemia of infants.

Authors:  R J CREMER; P W PERRYMAN; D H RICHARDS
Journal:  Lancet       Date:  1958-05-24       Impact factor: 79.321

2.  Spectrophotometric analysis of follicular fluid related to oocyte fertilization, embryo cleavage, and follicular fluid protein and hormone content.

Authors:  S R Bayer; B J Ransil; S J Shelton; D R Armant
Journal:  Fertil Steril       Date:  1990-10       Impact factor: 7.329

3.  An analysis of human oocytes and follicles from stimulated cycles: oocyte morphology and associated follicular fluid characteristics.

Authors:  P L Nayudu; A Lopata; G M Jones; D A Gook; H M Bourne; S J Sheather; T C Brown; W I Johnston
Journal:  Hum Reprod       Date:  1989-07       Impact factor: 6.918

4.  Oral contraceptive pills and follicular fluid hormones in an in vitro fertilization program.

Authors:  Z Weisman; M Dirnfeld; A Lissak; Y Sorokin; H Abramovici
Journal:  Fertil Steril       Date:  1989-09       Impact factor: 7.329

5.  Relationship of human oocyte maturity, fertilization, and cleavage to follicular fluid prolactin and steroids.

Authors:  M S Lee; Z Ben-Rafael; F Meloni; L Mastroianni; G L Flickinger
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-06

6.  Relationship between intrafollicular levels of prolactin and sex steroids and in-vitro fertilization of human oocytes.

Authors:  I E Messinis; A A Templeton
Journal:  Hum Reprod       Date:  1987-10       Impact factor: 6.918

7.  Elevated tissue type plasminogen activator in human granulosa cells correlates with fertilizing capacity.

Authors:  J Deutinger; J C Kirchheimer; A Reinthaller; G Christ; G Tatra; B R Binder
Journal:  Hum Reprod       Date:  1988-07       Impact factor: 6.918

8.  Phase II of a successful university-based in vitro fertilisation programme. Changes incorporated.

Authors:  J V van der Merwe; P Truter; C Sevenster; A Grace; A Botes; M Wimmers; C de Milander; E Snyman
Journal:  S Afr Med J       Date:  1987-02-21

9.  In vitro fertilization and embryo transfer in Pretoria.

Authors:  J V van der Merwe; U M Irsigler; C de Milander; M S Wimmers; A D Botes; E Snyman; M S von Prince; Z Koch; P Hurter
Journal:  S Afr Med J       Date:  1984-10-27

10.  Comparison of plasma and follicular fluid hormone profiles following stimulation with HMG, with or without LHRH agonists, for in-vitro fertilization.

Authors:  C Firmin; J M Antoine; F Millot; S Alvarez; M Debray; C Tibi; D Cornet; J Salat-Baroux; P Laruelle
Journal:  Hum Reprod       Date:  1991-05       Impact factor: 6.918

View more
  6 in total

1.  The detection of blood contamination in human follicular fluid.

Authors:  P F Levay; C Huyser; F L Fourie; D J Rossouw
Journal:  J Assist Reprod Genet       Date:  1997-04       Impact factor: 3.412

2.  Freeze-thaw of human follicular fluid: influence on the biochemical profile.

Authors:  C Huyser; F R Fourie; P Levay
Journal:  J Assist Reprod Genet       Date:  1993-10       Impact factor: 3.412

3.  Interleukin-1 beta, interleukin-6, and growth hormone levels in human follicular fluid.

Authors:  C Huyser; F L Fourie; E Bosmans; P F Levay
Journal:  J Assist Reprod Genet       Date:  1994-04       Impact factor: 3.412

4.  Spectrophotometric analysis of human follicular fluid with regard to in vitro fertilization (IVF) parameters, follicular protein, and hormone content.

Authors:  C Huyser; F L Fourie; P Levay
Journal:  J Assist Reprod Genet       Date:  1993-07       Impact factor: 3.412

Review 5.  Creatine Metabolism in Female Reproduction, Pregnancy and Newborn Health.

Authors:  Anna Maria Muccini; Nhi T Tran; Deborah L de Guingand; Mamatha Philip; Paul A Della Gatta; Robert Galinsky; Larry S Sherman; Meredith A Kelleher; Kirsten R Palmer; Mary J Berry; David W Walker; Rod J Snow; Stacey J Ellery
Journal:  Nutrients       Date:  2021-02-02       Impact factor: 5.717

6.  Impact of exogenous gonadotropin stimulation on circulatory and follicular fluid cytokine profiles.

Authors:  N Ellissa Baskind; Nicolas M Orsi; Vinay Sharma
Journal:  Int J Reprod Med       Date:  2014-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.